trial · primary record
dapansutrile
Parkinson Disease
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 36 |
| Primary completion | 2028-06 |
| Primary endpoint | Number of adverse events (AEs) recorded during the 6-month double-blind period |
| Registry ID | NCT07157735 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:45.177Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07157735
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.